Schooner Capital

Schooner Capital is a privately held growth equity investor based in Boston, with healthcare positions across care delivery, tech-enabled services, and life sciences tools. The firm is not AI-focused; its mandate is broader resilience-oriented growth investing, and healthcare is one of several sectors it engages with. For founders, that means Schooner is unlikely to act as a domain-deep partner the way a healthcare-only fund would, but it can offer flexible growth capital to companies with strong fundamentals.

The firm deploys $5M to $25M checks at the growth stage. That positions it for minority or co-investor positions in established healthcare services and tools businesses with revenue, predictable cash flows, and clear expansion plans. Schooner is unlikely to lead early-stage venture rounds.

Founders should approach Schooner when their healthcare services or life sciences tools company is past the early-stage risk window — meaningful revenue, a credible growth plan, and either profitability or a clear path to it. Pre-revenue companies, biotech, and digital health point solutions without traction are unlikely to fit. Because the firm is a generalist growth investor with healthcare exposure rather than a healthcare specialist, founders should bring a clean financial story that does not require deep clinical or regulatory translation. Expect a partner more interested in business model durability and cash generation than in the nuances of a particular therapeutic or clinical workflow. Position the pitch around fundamentals.